ARS Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRY and other ETFs, options, and stocks.

About SPRY

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. 

CEO
Richard E. Lowenthal
CEORichard E. Lowenthal
Employees
160
Employees160
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2015
Founded2015
Employees
160
Employees160

SPRY Key Statistics

Market cap
1.70B
Market cap1.70B
Price-Earnings ratio
-105.59
Price-Earnings ratio-105.59
Dividend yield
Dividend yield
Average volume
1.28M
Average volume1.28M
High today
$17.70
High today$17.70
Low today
$17.07
Low today$17.07
Open price
$17.59
Open price$17.59
Volume
1.17M
Volume1.17M
52 Week high
$18.90
52 Week high$18.90
52 Week low
$8.91
52 Week low$8.91

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own SPRY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.